CLASS II Drug recall · Reported 30 Dec 2020 · FDA Enforcement Report

Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg recalled

Morton Grove Pharmaceuticals is recalling Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg, distributed nationwide in the US. The recall was initiated on 9 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot#: a) UU1328, Exp 10/21; b) UU1207, Exp 07/21; UU1326, Exp 09/21; UU1327, Exp 10/21.
Quantity recalled127,392 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0174-2021
FDA event ID
86904
Recalling firm
Morton Grove Pharmaceuticals, Morton Grove, IL
Classification
Class II
Status
Terminated
Recall initiated
9 Dec 2020
FDA classified
23 Dec 2020
Reported
30 Dec 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

9 Dec 2020Recall initiated by company
23 Dec 2020Classified by FDA+14 days
30 Dec 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL) bottle, NDC 60432-150-04, b) 1 pint (473 mL), NDC 60432-150-16, Rx Only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053

Where it was distributed

Nationwide USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.

Which lots are affected?

Lot#: a) UU1328, Exp 10/21; b) UU1207, Exp 07/21; UU1326, Exp 09/21; UU1327, Exp 10/21.

Where was it sold?

Nationwide USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Morton Grove Pharmaceuticals

All 9

Other Hydroxyzine recalls

All 16